|Bid||51.70 x 28400|
|Ask||51.71 x 2100|
|Day's range||51.19 - 51.81|
|52-week range||39.91 - 69.00|
|Beta (5Y monthly)||1.30|
|PE ratio (TTM)||N/A|
|Earnings date||05 Aug 2021|
|Forward dividend & yield||2.00 (3.96%)|
|Ex-dividend date||28 Apr 2021|
|1y target est||119.69|
Bayer (BAYRY) submits an sNDA in the United States and an MAA in Europe for the combo of copanlisib and rituximab to treat two types of cancer indication.
Novartis' (NVS) rare kidney disease candidate meets its primary goal in a phase II study.
The U.S. Supreme Court rejects J&J's (JNJ) appeal against a lower court verdict of $2.1 billion in damages in a litigation related to its talc-based baby powder.